Cigna's pharmacy benefits unit Evernorth said the deal will bring prices down for employers and their workers.

The Cigna Group (NYSE:CI)’s Evernorth division has announced a new deal with Novo Nordisk and Eli Lilly that will limit ...

Cigna’s Evernorth has introduced a new pharmacy benefit that caps out-of-pocket costs for GLP-1 weight loss medications at $200 per month, in a move analysts say is more favorable for Eli Lilly ...

Cigna Group’s drug benefit unit is offering a new way for health plans to cover expensive weight-loss drugs that it says will ...

Investing.com -- Cigna’s Evernorth has introduced a new ... in a move analysts say is more favorable for Eli Lilly (NYSE:LLY) than rival models. Announced late Wednesday, the offering covers ...

The new weight-loss option will cut what the plan sponsors pay as well as what the patients pay, Cigna’s PBM Evernorth says.

Cigna will cap out-of-pocket costs at $200 per month for patients using the weight-loss drugs Wegovy and Zepbound through an ...

Morgan Stanley’s analysis is based on conversations with Eli Lilly’s Investor Relations regarding the Cigna/Evernorth announcement. Eli Lilly’s IR outlined several key points of the ...

While Cigna would not discuss the actual discounts ... And so that means that if you're Eli Lilly, you have to try and compete in the Medicare market with a product that's going to be on formulary ...